Skip to content Skip to footer
Working together

Shareholders &

Welcome to the Investors and Partners section of PROVIREX Genome Editing Therapies GmbH. We are a pioneering biotech company dedicated to the development of cutting-edge Advanced Therapy Medicinal Products (ATMPs) that have the potential to revolutionize the field of genome editing and combat life-threatening persistent virus infections.

Working together

Partnerships &

For inquiries about investment or partnership opportunities, please contact us at

Our Shareholders

Our Partners

Genome Editing Therapies GmbH

Luruper Hauptstraße 1
22547 Hamburg


Copyright © PROVIREX Genome Editing Therapies GmbH 2023